Vera Therapeutics enters up to $500M loan facility with Oxford Finance; $75M initial draw

Vera Therapeutics, Inc.

Initial $75M funded June 4, 2025; remaining $50M from $125M first tranche drawable in 2026.
Additional tranches: up to $175M upon milestones, plus $200M uncommitted subject to mutual agreement.
Interest rate: greater of 1-Month Term SOFR + 4.95% and 8.70%; maturity June 2030 or 2031.
Collateral on substantially all assets except IP; financial covenants require minimum liquidity or loan coverage ratios.
Facility fee 0.75% of funded amount; final payment and prepayment fees apply.

item 1.01item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.